2021
|
Invention
|
Oxadiazepinone derivatives and methods of treating hepatitis b infections.
Provided herein are c... |
|
Invention
|
Diazepinone derivatives and their use in the treatment of hepatitis b infections.
Provided herei... |
2019
|
Invention
|
Derivatives and methods of treating hepatitis b infections.
Provided herein are compounds useful... |
|
Invention
|
Combinations and methods comprising a capsid assembly inhibitor. The present disclosure is direct... |
2018
|
Invention
|
Combination therapy for treatment of hbv infections. Provided herein is a combination therapy com... |
|
Invention
|
Sulfide alkyl compounds for hbv treatment. The present invention includes a method of inhibiting,... |
|
Invention
|
Derivatives and methods of treating hepatitis b infections. Provided herein are compounds useful ... |
|
Invention
|
Pyridyl reverse sulfonamides for hbv treatment. The present invention includes a method of inhibi... |
2017
|
Invention
|
Azepane derivatives and methods of treating hepatitis b infections. Provided herein are compounds... |
|
Invention
|
Azocane and azonane derivatives and methods of treating hepatitis b infections. Provided herein a... |
|
Invention
|
Metabolic restriction in cell-based assays.
Provided are methods and assays used in the screenin... |
|
Invention
|
Metabolic restriction in cell-based assays. Provided are methods and assays used in the screening... |
|
Invention
|
Oxadiazepinone derivatives and methods of treating hepatitis b infections. Provided herein are co... |
|
Invention
|
Diazepinone derivatives and their use in the treatment of hepatitis b infections. Provided herein... |
|
Invention
|
Oxadiazepinone derivatives and their use in the treatment of hepatitis b infections. Provided her... |
|
Invention
|
Hepatitis b antiviral agents. The present invention includes a method of inhibiting, suppressing ... |
2016
|
Invention
|
Combination therapy for treatment of hbv infections. a, or another interferon analog. |
|
Invention
|
Crystalline forms of a hepatitis b antiviral agent. This disclosure provides crystalline forms of... |
2015
|
Invention
|
Sulfide alkyl and pyridyl reverse sulfonamide compounds for hbv treatment. The present invention ... |
|
Invention
|
Hepatitis b antiviral agents. Provided herein are compounds useful for the treatment of HBV infec... |